Pharmacology:bendamustine is an alkylating agent (nitrogen mustard derivative).use: labeled indicationschronic lymphocytic leukemia: treatment of chronic lymphocytic leukemia (cll)non-hodgkin lymphoma: treatment of indolent b-cell non-hodgkin lymphoma (nhl) which has progressed during or within 6 months of rituximab treatment or a rituximab-containing regimen.